U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07697222) titled 'SPSIPB Versus SAPB for Postoperative Analgesia After Minimally Invasive Repair of Pectus Ex... Read More
U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07699380) titled 'METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Di... Read More
U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07699770) titled 'Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Expl... Read More
U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07698847) titled 'Patient Education and AI-Assisted Complaint Summaries in Endodontic Patients' on July 07. ... Read More
U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07698015) titled 'Rehabilitation, Education, and SElf-management for Adolescents After Mild Traumatic Brain I... Read More
Singapore, July 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... Read More
Singapore, July 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More
Singapore, July 14 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More
Singapore, July 14 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More
Singapore, July 14 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More